Emergency medicine

In First Quarter 2022, Relatively Sharp Increase in In-Network Care Occurred as the No Surprises Act Came into Effect

Retrieved on: 
Tuesday, February 20, 2024

NEW YORK, Feb. 20, 2024 /PRNewswire/ -- In-network care increased across all professional specialties in facility settings from the first quarter of 2019 to the third quarter of 2023 nationally and in all regions. During that period, in-network care as a percentage of all claim lines increased 7.0 percent nationally, from 84.1 percent of claim lines in the first quarter of 2019 to 90.0 percent in the third quarter of 2023.1 The increase varied from 4.8 percent in the Northeast to 8.3 percent in the Midwest and South. From the fourth quarter of 2021 to the first quarter of 2022, a relatively sharp increase nationally (2.3 percent) and in all regions occurred across all specialties at the time the No Surprises Act (NSA) went into effect. These and other findings are reported in a FAIR Health white paper released today: In-Network and Out-of-Network Utilization and Pricing: A Study of Private Healthcare Claims.

Key Points: 
  • From the fourth quarter of 2021 to the first quarter of 2022, a relatively sharp increase nationally (2.3 percent) and in all regions occurred across all specialties at the time the No Surprises Act (NSA) went into effect.
  • These and other findings are reported in a FAIR Health white paper released today: In-Network and Out-of-Network Utilization and Pricing: A Study of Private Healthcare Claims .
  • On the federal level, the NSA went into effect on January 1, 2022.
  • The increase in in-network care for specialties of interest from the first quarter of 2019 to the third quarter of 2023 was 4.7 percent, versus 7.0 percent for all specialties.

Nitazenes are a powerful class of street drugs emerging across the US

Retrieved on: 
Thursday, February 15, 2024

Researchers have relatively little information on how the human body reacts to nitazenes because the drugs have never gone through clinical trials.

Key Points: 
  • Researchers have relatively little information on how the human body reacts to nitazenes because the drugs have never gone through clinical trials.
  • As law enforcement has cracked down on other drugs such as fentanyl, illegal labs have used historical pharmacology research to formulate analogs of nitazenes as street drugs.
  • Although nitazenes are now identified as illegal street drugs in numerous countries, many medical providers aren’t even aware they exist.
  • Nitazenes are also mixed with other street drugs such as heroin and fentanyl and with fake oxycodone pills, without users knowing it.

Vive Concierge, Inc. Announces Groundbreaking Expansion into Mental Health Services with Dr. Charles Sophy at the Helm

Retrieved on: 
Tuesday, February 13, 2024

Vive Concierge expands into mental health with Dr. Charles Sophy leading, focusing on underserved LA communities.

Key Points: 
  • Vive Concierge expands into mental health with Dr. Charles Sophy leading, focusing on underserved LA communities.
  • Dr. Charles Sophy, a distinguished psychiatrist with over 35 years experience, joins Vive Concierge as the Head of Mental Health and Wellness.
  • "Amidst a national mental health crisis, our mission at Vive Concierge is more vital than ever.
  • The introduction of mental health services is a key component of Vive Concierge's innovative Vive Care Connect platform, which revolutionizes care coordination and patient engagement.

Health Advocate Appoints Dr. Keri Robertson to Expand Clinical Care and Population Health Programs

Retrieved on: 
Tuesday, February 13, 2024

PLYMOUTH MEETING, Pa., Feb. 13, 2024 /PRNewswire/ -- Health Advocate, a leading provider of integrated health advocacy and navigation, population health, well-being, behavioral health, and worksite screening programs, announced today that it has added Dr. Keri Robertson to their team of medical directors.

Key Points: 
  • As a Medical Director, Robertson will combine her data-driven healthcare experience with her passion for care equity to enhance the company's population health programs.
  • PLYMOUTH MEETING, Pa., Feb. 13, 2024 /PRNewswire/ -- Health Advocate, a leading provider of integrated health advocacy and navigation, population health, well-being, behavioral health, and worksite screening programs, announced today that it has added Dr. Keri Robertson to their team of medical directors.
  • Dr. Robertson will play a key leadership role in support of the company's Clinical Care Management and Population Health Management solutions with a specific focus on data analytics and social determinants of health.
  • "As Health Advocate continues to improve our industry-leading solutions, Dr. Robertson is perfectly positioned to enhance the quality of support and care for our members who face serious medical issues," said Jeff Cordell, President and CEO, Health Advocate.

Tonix Pharmaceuticals Announces FDA IND Clearance for DoD Funded Trial of TNX-102 SL for the Reduction of Acute Stress Reaction and Prevention of PTSD

Retrieved on: 
Monday, February 12, 2024

CHATHAM, N.J., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products and a pipeline of development candidates, today announced the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for the Phase 2 investigator-initiated OASIS trial to evaluate TNX-102 SL1 in reducing the severity of acute stress reaction (ASR) and the frequency of acute stress disorder (ASD) and posttraumatic stress disorder (PTSD). The trial is sponsored by The University of North Carolina (UNC) Institute for Trauma Recovery and supported by a $3 million grant from the U.S. Department of Defense (DoD).

Key Points: 
  • “There is an unmet need for treating ASR after traumatic events such as civilian motor vehicle collisions or warfighter experiences in forward bases or in theater.
  • Participants will be randomized in the ED to receive a two-week course of either TNX-102 SL 5.6 mg or placebo.
  • The OASIS trial will build upon a foundation of knowledge and infrastructure developed through the UNC-led, $40 million AURORA initiative.
  • AURORA is a major national research initiative to improve the understanding, prevention, and recovery of individuals who experience a traumatic event.

Nym Named to New York Digital Health 100 for Third Consecutive Year

Retrieved on: 
Thursday, February 8, 2024

Nym , the leader in autonomous medical coding, today announced that, for the third year in a row, it has been named to Digital Health New York’s (DHNY) Digital Health 100, which celebrates the most innovative and exciting health startups in New York.

Key Points: 
  • Nym , the leader in autonomous medical coding, today announced that, for the third year in a row, it has been named to Digital Health New York’s (DHNY) Digital Health 100, which celebrates the most innovative and exciting health startups in New York.
  • DHNY recognized Nym for its multi-specialty autonomous medical coding solution and the impact it’s had on reducing costly administrative burdens associated with medical coding and billing.
  • “It’s an honor to be named to the Digital Health 100 list for the third time and to be among such innovative, disruptive companies that are transforming healthcare,” said Julien Dubuis, Chief Commercial Officer at Nym.
  • “2024 marks the fifth year of the New York Digital Health 100 and, in that time, the digital health ecosystem in New York has significantly grown and evolved,” said Bunny Ellerin, co-founder and CEO, DHNY.

Ambience Healthcare Raises $70M to Scale the Most Comprehensive AI Operating System for Healthcare Organizations

Retrieved on: 
Tuesday, February 6, 2024

SAN FRANCISCO, Feb. 6, 2024 /PRNewswire/ -- Ambience Healthcare , the most comprehensive AI operating system for healthcare organizations, has announced a $70M Series B raise co-led by Kleiner Perkins and OpenAI Startup Fund.

Key Points: 
  • SAN FRANCISCO, Feb. 6, 2024 /PRNewswire/ -- Ambience Healthcare , the most comprehensive AI operating system for healthcare organizations, has announced a $70M Series B raise co-led by Kleiner Perkins and OpenAI Startup Fund.
  • The Ambience AI operating system consists of a holistic suite of applications, designed to alleviate clinician burnout, improve overall system efficiency, and enable high-quality care.
  • Other key technical product features include the ability to:
    By customizing the Ambience AI operating system for each clinical specialty, healthcare systems have seen rapid adoption among clinicians.
  • Ambience's platform approach also enables healthcare organizations to break down silos and achieve significant improvements to overall system efficiency.

Zenith American Solutions Appoints Patrick Horne to EVP, Chief Information Officer

Retrieved on: 
Monday, February 5, 2024

TAMPA, Fla., Feb. 5, 2024 /PRNewswire/ -- Zenith American Solutions, Inc.("Zenith"), the leader in third-party administration services for Taft-Hartley trust funds, is pleased to announce that Patrick Horne has joined Zenith's Executive Leadership Team as the Company's Chief Information Officer.

Key Points: 
  • TAMPA, Fla., Feb. 5, 2024 /PRNewswire/ -- Zenith American Solutions, Inc.("Zenith"), the leader in third-party administration services for Taft-Hartley trust funds, is pleased to announce that Patrick Horne has joined Zenith's Executive Leadership Team as the Company's Chief Information Officer.
  • Patrick Horne has been an IT professional for over thirty-two years, managing IT operations for publicly traded and privately held companies.
  • Prior to joining Zenith American Solutions, Horne served as the Chief Information Officer at Southeast Medical Group based in Alpharetta, Georgia.
  • Horne said, "I am honored to assume the role of Chief Information Officer at such a reputable company.

Study Highlights Outcomes of New Jersey's 2017 Opioid Legislation

Retrieved on: 
Tuesday, January 30, 2024

Millburn, NJ, Jan. 30, 2024 (GLOBE NEWSWIRE) -- A recent study conducted at Morristown Medical Center, titled "New legislation in New Jersey reduced opioid use among trauma patients," provides an analysis of the effects of New Jersey's 2017 opioid legislation.

Key Points: 
  • Millburn, NJ, Jan. 30, 2024 (GLOBE NEWSWIRE) -- A recent study conducted at Morristown Medical Center, titled "New legislation in New Jersey reduced opioid use among trauma patients," provides an analysis of the effects of New Jersey's 2017 opioid legislation.
  • This change was based on evidence suggesting the potential for opioid dependency within a short period of initial use.
  • Findings from the Morristown Medical Center study indicate a correlation between the new law and a change in opioid prescription patterns.
  • "The findings from these studies provide insights into the impact of New Jersey's 2017 opioid legislation,” said Angelo Valente, Executive Director of PDFNJ.

US Acute Care Solutions Expands Partnership with Inova Health System to Include Comprehensive Emergency Medicine Services at Inova Fairfax Medical Campus

Retrieved on: 
Wednesday, January 31, 2024

US Acute Care Solutions (USACS), the nation’s largest physician-owned and led acute care practice, is honored to announce the expansion of its partnership with Inova Health System to include four additional programs.

Key Points: 
  • US Acute Care Solutions (USACS), the nation’s largest physician-owned and led acute care practice, is honored to announce the expansion of its partnership with Inova Health System to include four additional programs.
  • Effective January 1, 2024, USACS welcomed the existing emergency medicine physicians and advanced practice providers from the Inova Fairfax Medical Campus (IFMC), which includes the adult emergency department at Inova Fairfax Hospital and the Inova L.J.
  • The expanded partnership will also include two freestanding emergency departments:
    This is an expansion of a partnership that began 23 years ago when Emergency Medicine Associates, one of the 20 physician groups that have since joined USACS, began providing emergency medicine services to Inova Alexandria Hospital.
  • USACS has consistently demonstrated a commitment to providing the highest-quality medical care to our shared patients in this community.”